The call was at 9.30 EDT. I dialled in and it was the standard call which re-stated recent releases and opened the floor to questions.
There were some great well-informed questions pertaining to interim results and range/P values, commercial roll-out, Pan-Co, potential flexibility of end-points for pivotal study, and of course progress in CE mark review by BSI. Directors are still extremely confident of receiving CE mark and this was backed-up by the types of questions/clarifications BSI continue to field (regarding manufacture, storage, transport, sterility, calibration doses etc.) which would indicate the review is in its closing stages.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 192 | $1.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6234 | 1 |
View Market Depth
| Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |